IO Clinical Trials is part of the IO360˚ conference and is a great one day program for clinical trial operation professionals
02-08-2018 | 08:30 - 18:30 ET New York NY
Your browser does not support the video tag. 39th Annual Meeting & Pre-Conference Programs Nov. 6–10, 2024 | Houston, TX | #SITC24 April 24, 2024 Regular & Young Investigator Abstract Submissions Open May 2024 Registration Opens June 27, 2024 Regular & Young Investigator Abstract Submissions Close July 15, 2024 Late-Breaking Abstract Submissions Open Sept. 12, 2024 Late-Breaking Abstract Submissions Close Advance the science, discover breakthroughs and educate the world on cancer immunotherapy
Discovery/Pre-Clinical Imaging Advancements Clinical Developments Clinical Operations Business Developments RNA Therapeutics Cell Therapy Translational Science
02-07-2023 07:30 - 02-10-2023 15:35 ET
SITC ACI attendees benefit from: Updates on the latest clinical advances in cancer immunotherapy, including data from recent scientific meetings and clinical trials An overview of common approaches to cancer immunotherapy and their related mechanisms Dedicated opportunities for clinicians to ask questions and receive direction on difficult cases Strategies for addressing the practical barriers to implementing immunotherapy (operations, reimbursement and management of emerging toxicities) SITC ACI programs are certified for CME, CNE, CPE, and MOC credits
Discovery/Pre-Clinical Imaging Advancements Bispecifics Clinical Operations Business Developments NeoAdjuvant/Adjuvant Cell and Gene Therapy Translational Science Clinical Developments For more information please visit: www.io360summit.com
03-16-2022 08:15 - 03-18-2022 15:50 ET Brooklyn NY
Luke's Cancer Center This webinar focused on effective practices for incorporating immunotherapy into hospital operations. Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date
Advances in Cancer Immunotherapy™ Post-Program Webinar 2 (Dallas).mp4
Quick-reference tables summarizing pivotal trial data for approved immunotherapy agents for GI cancer. Add a tag
The 7th annual Immuno-Oncology 360° Summit is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate. 2021 Key Topic Areas Discovery/Preclinical Science Cell & Gene Therapy Translational Science Bispecifics Clinical Developments Neoadjuvant/Adjuvant Data Emerging Biomarkers Vaccines Clinical Operations AI & Machine Learning Imaging Advancements Business Developments Use the code SITC10 for a 10% discount
02-23-2021 08:00 - 02-26-2021 17:00 ET
Webinar Faculty: Una Hopkins, RN, FNP-BC, DNP – White Plains Hospital This webinar focused on coverage and reimbursement strategies and how to incorporate immunotherapy into hospital operations. Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date
Advances in Cancer Immunotherapy™ Post-Program Webinar 2 (Buffalo).mp4
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us